Brainstorm Award

Objective

The objective of the Brainstorm Awards is to foster interdisciplinary collaborations encompassing novel, hypothesis-driven studies of cancer or a cancer-related topic. The proposed project must be a joint, collaborative effort by at least two Cancer Center members from different programs or different disciplines, and must represent a new collaborative proposal.  The Masonic Cancer Center is especially interested in Brainstorm Award applications that are focused on projects relevant to solid tumor oncology with translational potential.  Projects that meet these criteria will be prioritized for funding, although it is not a prerequisite for application submission.

Grant Program Contacts

All questions related to the application process, requirements, or eligibility should be directed to:
Jessica Raines-Jones
Research Development Coordinator
612-624-8679
mccgrant@umn.edu

Any questions regarding the applicability of research should be directed to:
Anja Bielinsky, PhD
bieli003@umn.edu

Previous Grantees

2018

4D Engineered In Vitro Models of Metastasis and Drug Screening
Angela Panoskaltsis-Mortari, PhD, Department of Pediatrics, Medical School
Michael McAlpine, PhD, Department of Mechanical Engineering, College of Science and Engineering

Enhancing pancreatic cancer immunotherapy through parallel murine and human tumor antigen receptor engineering
Beau Webber, PhD, Department of Pediatrics, Medical School
Ingunn Stromnes, PhD, Department of Microbiology and Immunology, Medical School 

Potentiation of Immune Checkpoint Blockade by Inhibition of Epoxyeicosatrienoic Acid Driven Tumor Respiration
David Potter, MD, PhD, Department of Medicine, Medical School
Michael Farrar, PhD, Department of Laboratory Medicine and Pathology, Medical School

2017

Molecular dissection of PELP1 protein interactions
Julie Ostrander, PhD, Department of Medicine, Medical School
Hideki Aihara, PhD, Department of Biochemistry, Molecular Biology, and Biophysics, Medical School
 
Using adrenergic receptor antagonists to inhibit sarcoma growth and enhance T cell responses
Erin Dickerson, PhD, Department of Veterinary Clinical Sciences, College of Veterinary Medicine
Stephen Jameson, PhD, Department of Laboratory Medicine and Pathology, Medical School

2016

Tumor-infiltrating Eosinophils: A Protective Role in Colorectal Cancer
Anna Prizment, PhD, Epidemiology and Community Health, School of Public Health
Robert Cormier, PhD, Department of Biomedical Sciences, Medical School, UMD

The Development of a PEG10 Promoter Driven Theranostic for Castration-Resistant Prostate Cancer
Aaron LeBeau, PhD, Department of Pharmacology, Medical School
Gregory Metzger, PhD, Department of Radiology, Medical School

2014

A Paradoxical Role for Hypoxia-Inducible Factor Signaling in Pancreas Cancer
Paolo Provenzano, PhD, Department of Biomedical Engineering, College of Science and Engineering
Anindya Bagchi, PhD, Department of Urology, Medical School

Targeting Deubiquinating Enzymes (DUBs) as Therapeutic Targets to Overcome Drug Resistance in Diverse Cancers
Brian VanNess, PhD, Department of Genetics, Cell Biology and Development, College of Biological Sciences
Martina Bazzaro, PhD, Department of Obstetrics, Gynecology and Women’s Health, Medical School

 

2013

Improved NK Cell-mediated Anti-ovarian Cancer Response via Disruption of CD16a Down-regulation
Daniel Kaufman, MD, PhD, Department of Medicine, Medical School
Bruce Walcheck, PhD, Department of Veterinary and Biomedical Sciences, College of Veterinary Medicine

Synthetic Inhibitors of CD44/Hyaluronan Interactions
James McCarthy, PhD, Department of Laboratory Medicine and Pathology, Medical School
Barry Finzel, PhD, Department of Medicinal Chemistry, College of Pharmacy 

2012

Comparative Analysis of Repair and Checkpoint Capacities of Fanconi Anemia Cells
Anja Bielinsky, PhD, Department of Biochemistry, Molecular Biology, and Biophysics, College of Biological Sciences
Jakub Tolar, MD, PhD, Department of Pediatrics, Medical School

Development of Novel Monocarboxylate Transporter-1 Inhibitors for the Treatment of Gliomas
Lester Drewes, PhD, Department of Biomedical Sciences, Medical School, UMD
Venkatram Mereddy, PhD, College of Pharmacy, UMD

2011

Mechanism of Action and Prodrugs of RITA, a Small Molecule for MLL Leukemias
Robert Fecik, PhD, Department of Medicinal Chemistry, College of Pharmacy
John Kersey, MD, Department of Laboratory Medicine and Pathology, Medical School

Integration of Docetaxel into Nanorings for the Treatment of Prostate Cancer
Carston Wagner, PhD, Department of Medicinal Chemistry, College of Pharmacy
Gunda Georg, PhD, Department of Medicinal Chemistry, College of Pharmacy

2010

Proteomic Detection of Ovarian Cancer Biomarkers in Routine Pap Tests
Amy Skubitz, PhD, Department of Laboratory Medicine and Pathology, Medical School
Melissa Geller, MD, Department of Obstetrics, Gynecology and Women’s Health, Medical School

DNA-protein Cross-linking in Carcinogenesis and Antitumor Therapy
Natalia Tretyakova, PhD, Department of Medicinal Chemistry, College of Pharmacy
Colin Campbell, PhD, Department of Pharmacology, Medical School

Contact Us: 

Jessica Raines-Jones
Research Development Coordinator
612-624-8679
mccgrant@umn.edu

Elizabeth Fedie
Research Development Manager
612-624-0653
efedie@umn.edu 

David Largaespada, PhD
Associate Director for Basic Sciences

612-626-4979
larga002@umn.edu

Apply Here!

Funding Calendar